Can a common heart drug help patients with a Parasite-Linked lung disease?
NCT ID NCT07453030
Summary
This study aims to understand the long-term effects of an oral medication called selexipag in adults with a specific type of high blood pressure in the lungs caused by a parasitic infection (schistosomiasis). Researchers will compare the health outcomes of about 30 patients who received selexipag as part of their regular care to similar patients who did not receive it. This is an observational study, meaning it looks at existing medical records and does not change how patients are treated.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY ARTERIAL HYPERTENSION (PAH) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Instituto do Coração (InCor), Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo
São Paulo, São Paulo, 05403-900, Brazil
Conditions
Explore the condition pages connected to this study.